At the request of the exchanges, the U.S./Hong Kong stock quotes are displayed on a 15-minute delay, download the APP to view the real-time quotes for free.
Close
APC ARKO Petroleum Corp.
Pre-Mkt 07-31 08:56:23 EDT
20.18
+0.18
+0.90%
High20.60Low19.98Vol99.11K
Open20.04D1 Closing20.00Amplitude3.13%
Mkt Cap959.97MTradable Cap224.22MTotal Shares47.57M
T/O2.00MT/O Rate0.89%Tradable Shares11.11M
P/B--ROE--EPS0.00
52wk High--52wk Low--P/E--
Dividend--Div.Yield--ROA--

Loading ...

APC Minerals Steps Up Exploration Plans at Laverton Downs and Nexus Projects
TIPRANKS  ·  11:42
APC Minerals Steps Up Exploration Plans at Laverton Downs and Nexus Projects
Arko Petroleum Schedules Q2 Earnings Call
Reuters  ·  07-30 20:33
Arko Petroleum Schedules Q2 Earnings Call
ARKO Petroleum Corp. to Report Second Quarter 2026 Financial Results on August 6, 2026
GlobeNewswire  ·  07-30 20:30
ARKO Petroleum Corp. to Report Second Quarter 2026 Financial Results on August 6, 2026
Arko Petroleum Corp : Mizuho Raises Target Price to $22 from $20
THOMSON REUTERS  ·  07-28
Arko Petroleum Corp : Mizuho Raises Target Price to $22 from $20
This 'intrinsic Value' Small-cap Stock Strategy Keeps Benefiting from Deep Research
Dow Jones  ·  07-23
This 'intrinsic Value' Small-cap Stock Strategy Keeps Benefiting from Deep Research
7 Eleven Deal Puts Convenience Store Stocks Back On Retail Investor Radar
Simply Wall St.  ·  07-17
7 Eleven Deal Puts Convenience Store Stocks Back On Retail Investor Radar
EULAR 2026: Dapirolizumab Pegol Shows Potential to Reduce Flare Rates and Maintain Disease Control in Systemic Lupus Erythematosus
GlobeNewswire  ·  06-04
EULAR 2026: Dapirolizumab Pegol Shows Potential to Reduce Flare Rates and Maintain Disease Control in Systemic Lupus Erythematosus
HeartSciences Launches MyoVista Insights™ Version 1.3 with AI-ECG Algorithm Marketplace and First FDA-Cleared Algorithm
GlobeNewswire  ·  06-02
HeartSciences Launches MyoVista Insights™ Version 1.3 with AI-ECG Algorithm Marketplace and First FDA-Cleared Algorithm
UCB and Biogen Announce Publication in The Lancet of Positive Dapirolizumab Pegol (DZP) Phase 3 Study Results in Systemic Lupus Erythematosus
GlobeNewswire  ·  06-01
UCB and Biogen Announce Publication in The Lancet of Positive Dapirolizumab Pegol (DZP) Phase 3 Study Results in Systemic Lupus Erythematosus
Systemic immune activation with eftilagimod alfa associated with statistically significant increased overall survival in late-stage cancer patients
GlobeNewswire  ·  05-28
Systemic immune activation with eftilagimod alfa associated with statistically significant increased overall survival in late-stage cancer patients
Immutep Reports Survival Benefit Linked to Immune Response in Efti Clinical Trial Analysis
MT Newswires Live  ·  05-28
Immutep Reports Survival Benefit Linked to Immune Response in Efti Clinical Trial Analysis
UPDATE -- Powerus Selected to Compete in Phase II of Pentagon's $1 Billion Drone Dominance Program
GlobeNewswire  ·  05-28
UPDATE -- Powerus Selected to Compete in Phase II of Pentagon's $1 Billion Drone Dominance Program
ARKO Petroleum Corp. Class A (APC) Receives a Rating Update from a Top Analyst
TIPRANKS  ·  05-14
ARKO Petroleum Corp. Class A (APC) Receives a Rating Update from a Top Analyst
Blackstone Holdings I disposes 125,000 Arko Petroleum common shares worth $2.38 million
Reuters  ·  05-13
Blackstone Holdings I disposes 125,000 Arko Petroleum common shares worth $2.38 million
Arko Petroleum files Form 3 initial beneficial ownership statement by Harvest Fund Advisors LLC
Reuters  ·  05-13
Arko Petroleum files Form 3 initial beneficial ownership statement by Harvest Fund Advisors LLC
Arko Petroleum reports Q1 EPS 20c, consensus 20c
TIPRANKS  ·  05-11
Arko Petroleum reports Q1 EPS 20c, consensus 20c
ARKO Petroleum Q1 Earnings Rise, Revenue Falls
MT Newswires Live  ·  05-11
ARKO Petroleum Q1 Earnings Rise, Revenue Falls
Earnings Flash (APC) ARKO Petroleum Posts Q1 EPS $0.20
MT Newswires Live  ·  05-11
Earnings Flash (APC) ARKO Petroleum Posts Q1 EPS $0.20
Arko Petroleum Q1 EPS $0.20 Beats $0.18 Estimate, Sales $1.344B Beat $1.290B Estimate.
Benzinga Earnings  ·  05-11
Arko Petroleum Q1 EPS $0.20 Beats $0.18 Estimate, Sales $1.344B Beat $1.290B Estimate.
Arko Petroleum Q1 net income rises 78.3% to $8.08 million; adjusted EBITDA climbs 17.7% to $36.36 million
Reuters  ·  05-11
Arko Petroleum Q1 net income rises 78.3% to $8.08 million; adjusted EBITDA climbs 17.7% to $36.36 million

Introduction

Company Name.
ARKO Petroleum Corp.
Affiliated Markets:
NASDAQ
Listing Date:
--
Main Business:
Anadarko Petroleum Corporation engages in the exploration, development, production, and marketing of oil and gas properties. It operates through three segments: Exploration and Production, WES Midstream, and Other Midstream. The company explores for and produces oil, natural gas, and natural gas liquids (NGLs). It also engages in gathering, processing, treating, and transporting oil, natural-gas, and NGLs production, as well as the gathering and disposal of produced water. The company's oil and natural gas properties are located in the United States onshore and deepwater Gulf of Mexico; and Algeria, Ghana, Mozambique, Colombia, and other countries. As of December 31, 2017, it had approximately 1.4 billion barrels of oil equivalent of proved reserves. Anadarko Petroleum Corporation was founded in 1959 and is headquartered in The Woodlands, Texas.
Issue price:
--